Membranous nephropathy

Last updated: February 23, 2023

Membranous nephropathy

Dr. Andrews

Dr. Andrews

Cell cycle
Oncogenes and tumor suppressor genes
Non-Hodgkin lymphoma
Hodgkin lymphoma
DiGeorge syndrome
Hydronephrosis
Acute pyelonephritis
Chronic pyelonephritis
Vesicoureteral reflux
Bladder exstrophy
BK virus (Hemorrhagic cystitis)
Non-urothelial bladder cancers
Development of the umbilical cord
Development of the fetal membranes
Dizziness and vertigo: Clinical
Reactive arthritis
Klinefelter syndrome
Testicular tumors: Pathology review
DNA alkylating medications
Androgens and antiandrogens
PDE5 inhibitors
Adrenergic antagonists: Alpha blockers
Estrogens and antiestrogens
Progestins and antiprogestins
Aromatase inhibitors
Uterine stimulants and relaxants
Anatomy of the pelvic cavity
Pelvic inflammatory disease
Vulvar cancer: Clinical
Vaginal and vulvar disorders: Pathology review
Chlamydia trachomatis
Papulosquamous skin disorders: Clinical
Transitional cell carcinoma
Human papillomavirus
Paget disease of the breast
Vascular tumors
Development of the digestive system and body cavities
Nephroblastoma (Wilms tumor)
Development of the renal system
Antimetabolites for cancer treatment
Hypothyroidism: Pathology review
Hashimoto thyroiditis
Hyperthyroidism: Pathology review
Thyroid cancer
Thyroid nodules and thyroid cancer: Pathology review
Riedel thyroiditis
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal masses and tumors: Clinical
Sheehan syndrome
Cervical cancer
Ovarian cyst
Pheochromocytoma
Multiple endocrine neoplasia: Pathology review
Carcinoid syndrome
Vaginal cancer: Clinical
Acromegaly
Multiple endocrine neoplasia
Parathyroid hormone
Cystic fibrosis
Preeclampsia & eclampsia
Necrotizing enterocolitis
Neonatal respiratory distress syndrome
Galactosemia
Phenylketonuria (NORD)
WAGR syndrome
Focal segmental glomerulosclerosis (NORD)
Nephrotic syndromes: Pathology review
Membranoproliferative glomerulonephritis
Nephritic syndromes: Pathology review
IgA nephropathy (NORD)
Diabetic nephropathy
Membranous nephropathy
Minimal change disease
Ribonucleotide reductase inhibitors
Alport syndrome
Rapidly progressive glomerulonephritis
Goodpasture syndrome
Neurogenic bladder
Polycystic ovary syndrome
Endometrial hyperplasia
Renal system anatomy and physiology
Medullary cystic kidney disease
Krukenberg tumor
Polycystic kidney disease
Multicystic dysplastic kidney
Medullary sponge kidney
Horseshoe kidney
The role of the kidney in acid-base balance
Pancreatic cancer
Pancreatic neuroendocrine neoplasms
Acute pancreatitis
Chronic pancreatitis
Microtubule inhibitors
Bordetella pertussis (Whooping cough)
Topoisomerase inhibitors
Breast cancer
Prostate disorders and cancer: Pathology review
Antidiuretic hormone
Estrogen and progesterone
Li-Fraumeni syndrome
Renal agenesis
Gene regulation
Familial adenomatous polyposis
Mendelian genetics and punnett squares
Uterine fibroid
Respiratory acidosis
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
Peutz-Jeghers syndrome
Anatomy of the perineum

Transcript

Watch video only

Content Reviewers

Membranous glomerulonephritis, also known as membranous nephropathy, is where the glomerular basement membrane, or GBM, which lines the glomeruli in the kidney, becomes inflamed and damaged, which results in increased permeability and proteins being able to filter through into the urine, causing nephrotic syndrome.

But what exactly is nephrotic syndrome? Well usually the glomerulus only lets small molecules, like sodium and water, move from the blood into the kidney nephron, where it eventually makes its way into the urine. But with nephrotic syndromes, the glomeruli are damaged and they become more permeable, so they start letting plasma proteins come across from the blood to the nephron and then into the urine, which causes proteinuria, typically greater than 3.5 grams per day.

An important protein in the blood is albumin, and so when it starts leaving the blood, people get hypoalbuminemia—low albumin in the blood.

With less protein in the blood the oncotic pressure falls, which lowers the overall osmotic pressure, which drives water out of the blood vessels and into the tissues, called edema.

Finally, it’s thought that as a result of either losing albumin or losing some protein or proteins that inhibit the synthesis of lipids, or fat, you get increased levels of lipid in the blood, called hyperlipidemia.

Just like the proteins, these lipids can also get into the urine, causing hyperlipiduria.

And those are the hallmarks of nephrotic syndrome—proteinuria, hypoalbuminemia, edema, hyperlipidemia, and lipiduria.

Alright, so with membranous glomerulonephritis, the basement membrane becomes damaged which causes nephrotic syndrome. How does this happen, though? Well, ultimately this damage is caused by immune complexes—complexes composed of an antigen with an antibody bound to it.

One way these complexes can form is as a result of autoantibodies directly targeting the glomerular basement membrane.

Two major antigen targets that’ve been identified are the M-type phospholipase A2 receptor and neutral endopeptidase, which are both expressed on the podocyte surface—the cells that line the basement membrane, and we know this because a large proportion of cases, people with membranous glomerulonephritis have antibodies against these autoantigens in their bloodstream.

Immune complexes, though, might also form outside of the kidney, and then get carried through the bloodstream to the glomerulus and deposit in the basement membrane.

One potential circulating antigen that’s been identified is cationic bovine serum albumin, which is present in cow’s milk and beef protein, and can escape the intestinal barrier, cause immune complex formation, and deposit in the GBM.

Whether they bind directly to the GBM, or come from somewhere else, these immune complexes are called subepithelial deposits because they’re sandwiched right between the epithelial cells or podocytes, and the GBM.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Membranous nephropathy in children: clinical presentation and therapeutic approach" Pediatric Nephrology (2009)
  6. "Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy" New England Journal of Medicine (2014)
  7. "Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome" Cochrane Database of Systematic Reviews (2014)
  8. "Membranous Glomerulopathy: Emphasis on Secondary Forms and Disease Variants" Advances in Anatomic Pathology (2001)